
Keywords: Antibiotics; Community-acquired pneumonia; Gram-positive bacteria; Healthcare-associated pneumonia; Methicillin-resistant Staphylococcus aureus; Novel antimicrobials; Skin and soft-tissue infections; Vancomycin-resistant Enterococcus faecium;